enVVeno Medical (NVNO) Accounts Payables (2017 - 2026)

enVVeno Medical has reported Accounts Payables for 10 years, with the latest figure at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 35.32% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 35.32% YoY), and the FY2025 full-year result was $358000.0, down 79.32% from the prior year.
• Accounts Payables for Q1 2026 stood at $1.7 million, up from $358000.0 in the prior quarter.
• The five-year high for Accounts Payables was $2.6 million in Q2 2025, with the low at $358000.0 in Q4 2025.
• Average Accounts Payables over 5 years is $1.3 million, with a median of $1.3 million recorded in 2025.
• Year-over-year, Accounts Payables surged 243.43% in 2023 and plunged 79.32% in 2025.
• Tracing NVNO's Accounts Payables over 5 years: stood at $1.2 million in 2022, then retreated by 15.05% to $1.0 million in 2023, then surged by 67.57% to $1.7 million in 2024, then sank by 79.32% to $358000.0 in 2025, then soared by 387.99% to $1.7 million in 2026.
• The last three Accounts Payables figures came in at $1.7 million (Q1 2026), $358000.0 (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.

Peer Comparison